With greatly reduced ILC development and expansion in blood cancers, conversion from NK or functional ILC to non-cytotoxic ILC is observed in murine models, allowing tumours to achieve immune evasion (Gao et al., 2017). Here, CCL27 is linked to hematopoietic and lymphoid system neoplasm.